Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Dissecting a complex chemical stress: chemogenomic profiling of plant hydrolysates.

Skerker JM, Leon D, Price MN, Mar JS, Tarjan DR, Wetmore KM, Deutschbauer AM, Baumohl JK, Bauer S, Ibáñez AB, Mitchell VD, Wu CH, Hu P, Hazen T, Arkin AP.

Mol Syst Biol. 2013 Jun 18;9:674. doi: 10.1038/msb.2013.30.

2.

Characterization of NaCl tolerance in Desulfovibrio vulgaris Hildenborough through experimental evolution.

Zhou A, Baidoo E, He Z, Mukhopadhyay A, Baumohl JK, Benke P, Joachimiak MP, Xie M, Song R, Arkin AP, Hazen TC, Keasling JD, Wall JD, Stahl DA, Zhou J.

ISME J. 2013 Sep;7(9):1790-802. doi: 10.1038/ismej.2013.60. Epub 2013 Apr 11.

3.

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators.

N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898.

4.

Functional characterization of Crp/Fnr-type global transcriptional regulators in Desulfovibrio vulgaris Hildenborough.

Zhou A, Chen YI, Zane GM, He Z, Hemme CL, Joachimiak MP, Baumohl JK, He Q, Fields MW, Arkin AP, Wall JD, Hazen TC, Zhou J.

Appl Environ Microbiol. 2012 Feb;78(4):1168-77. doi: 10.1128/AEM.05666-11. Epub 2011 Dec 9.

5.

Evidence-based annotation of gene function in Shewanella oneidensis MR-1 using genome-wide fitness profiling across 121 conditions.

Deutschbauer A, Price MN, Wetmore KM, Shao W, Baumohl JK, Xu Z, Nguyen M, Tamse R, Davis RW, Arkin AP.

PLoS Genet. 2011 Nov;7(11):e1002385. doi: 10.1371/journal.pgen.1002385. Epub 2011 Nov 17.

6.

MicrobesOnline: an integrated portal for comparative and functional genomics.

Dehal PS, Joachimiak MP, Price MN, Bates JT, Baumohl JK, Chivian D, Friedland GD, Huang KH, Keller K, Novichkov PS, Dubchak IL, Alm EJ, Arkin AP.

Nucleic Acids Res. 2010 Jan;38(Database issue):D396-400. doi: 10.1093/nar/gkp919. Epub 2009 Nov 11.

7.

Disability payments, drug use and representative payees: an analysis of the relationships.

Swartz JA, Hsieh CM, Baumohl J.

Addiction. 2003 Jul;98(7):965-75.

PMID:
12814502
8.

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.

Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J.

Br J Cancer. 2000 Nov;83(9):1128-35.

9.

A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.

Sculier JP, Paesmans M, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Bureau G, Berchier MC, Zacharias C, Mommen P, Bosschaerts T, Berghmans T, van Houtte P, Ninane V, Klastersky J.

Ann Oncol. 1999 Mar;10(3):295-303.

PMID:
10355573
10.

Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.

Sculier JP, Paesmans M, Ninane V, Giner V, Bureau G, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Berchier MC, Zacharias C, Mommen P, van Houtte P, Klastersky J.

Lung Cancer. 1998 Dec;22(3):201-13.

PMID:
10048473
11.

The preference for GT-rich DNA by the yeast Rad51 protein defines a set of universal pairing sequences.

Tracy RB, Baumohl JK, Kowalczykowski SC.

Genes Dev. 1997 Dec 15;11(24):3423-31.

12.

Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group study.

Jassem J, Gyergyay F, Kerpel-Fronius S, Nagykálnai T, Baumöhl J, Verweij J, Vuletic L, Mechl Z, Drozd-Lula M, Jelic S, et al.

Cancer Chemother Pharmacol. 1993;31(6):489-94.

PMID:
8453690
13.

Addiction and the American debate about homelessness.

Baumohl J.

Br J Addict. 1992 Jan;87(1):7-10; discussion 11-6. No abstract available.

PMID:
1543941
15.

Inebriate institutions in North America, 1840-1920.

Baumohl J.

Br J Addict. 1990 Sep;85(9):1187-204.

PMID:
2224199
16.

[Optimization of radiotherapy of lung carcinoma].

Baumöhl J, Jurga L, Matula P, Rexová J.

Cesk Radiol. 1988 Oct;42(5):349-56. Slovak. No abstract available.

PMID:
3219740
17.

[Radiation injuries of the spinal cord].

Baumöhl J, Baumöhlová H.

Cesk Radiol. 1988 Aug;42(4):275-80. Slovak. No abstract available.

PMID:
3224394
18.

Combined chemotherapy and radiotherapy in the treatment of advanced head and neck cancer using cisplatin.

Baumöhl J, Klimo J, Andrasina I, Jutka K.

Neoplasma. 1987;34(4):497-502.

PMID:
3658049
19.

Inebriety, doctors, and the state. Alcoholism treatment institutions before 1940.

Baumohl J, Room R.

Recent Dev Alcohol. 1987;5:135-74.

PMID:
3550910
20.

Cutting services to chronic inebriates represents no paradox of accessibility: a response to Kaufman and Walfish.

Speiglman R, Baumohl J, Wittman FD.

Int J Addict. 1986 Jul;21(7):843-6. No abstract available.

PMID:
3781695

Supplemental Content

Loading ...
Support Center